|
10 Feb 2014
|
GlaxoSmithKline
|
Chola Wealth Direct
|
10753.65
|
|
4305.25
(149.78%)
|
|
|
|
|
rates sustaining above 10%. Value-added variants of Horlicks account for ~18% of brand sales. With super premium MFDs priced at INR 1000 / Kg accounting for 10% of value and growing at 35%, GSK Consumer intends to enter the segment. Also, management aims to increase non-MFD segment's share from the current 5% to 15% over the next 3 years by focusing on Sensodyne toothpaste, noodles, oats, biscuits and nutri-bars. Reaches 800,000 outlets. GSK Consumer has a strong brand equity even in...
|
|
12 Nov 2013
|
GlaxoSmithKline
|
Chola Wealth Direct
|
10753.65
|
|
4463.55
(140.92%)
|
|
|
|
|
Background: GSK Consumer is the largest player in the Rs18b Indian health drink market, w ith a 70% market share. The category has entered a new orbit, with growth rates sustaining above 10%. Value-added variants of Horlicks account for ~18% of brand sales. With super premium MFDs priced at INR 1000 / Kg accounting for 10% of value and grow ing at 35%, GSK Consumer intends to enter the segment. Also, management aims to increase non-MFD segment's share from the current 5% to 15% over the next 3 years by focusing on Sensodyne toothpaste, noodles, oats, biscuits and nutri-bars. Reaches 800,000 outlets. GSK Consumer has a strong brand equity even in...
|
|
08 Aug 2013
|
GlaxoSmithKline
|
Chola Wealth Direct
|
10753.65
|
3846.00
|
3953.00
(172.04%)
|
|
Neutral
|
|
|
Background: GSK Consumer is the largest player in the Rs18b Indian health drink market, with a 70% market share. The category has entered a new orbit, with growth rates sustaining above 10%. Value-added variants of Horlicks account for ~18% of brand sales. With super premium MFDs priced at INR 1000 / Kg accounting for 10% of value and growing at 35%, GSK Consumer intends to enter the segment. Also, management aims to increase non-MFD segment's share from the current 5% to 15% over the next 3 years by focusing on Sensodyne toothpaste, noodles, oats, biscuits and nutri-bars. Reaches 800,000 outlets. GSK Consumer has a strong brand equity even in...
|
|
08 May 2013
|
GlaxoSmithKline
|
Chola Wealth Direct
|
10753.65
|
3846.00
|
3958.00
(171.69%)
|
|
Neutral
|
|
|
Background: GSK Consumer is the largest player in the Rs18b Indian health drink market, with a 70% market share. The category has entered a new orbit, with growth rates sustaining above 10%. Value-added variants of Horlicks account for ~18% of brand sales. With super premium MFDs priced at INR 1000 / Kg accounting for 10% of value and growing at 35%, GSK Consumer intends to enter the segment. Also, management aims to increase non-MFD segment's share from the current 5% to 15% over the next 3 years by focusing on Sensodyne toothpaste, noodles, oats, biscuits and nutri-bars. Reaches 800,000 outlets. GSK Consumer has a strong brand equity even in...
|
|
22 Feb 2013
|
GlaxoSmithKline
|
Chola Wealth Direct
|
10753.65
|
3796.00
|
3888.30
(176.56%)
|
|
Neutral
|
|
|
Background: GSK Consumer is the largest player in the Rs18b Indian health drink market, with a 70% market share. The category has entered a new orbit, with growth rates sustaining above 10%. Value-added variants of Horlicks account for ~18% of brand sales. With super premium MFDs priced at INR 1000 / Kg accounting for 10% of value and growing at 35%, GSK Consumer intends to enter the segment. Also, management aims to increase non-MFD segment's share from the current 5% to 15% over the next 3 years by focusing on Sensodyne toothpaste, noodles, oats, biscuits and nutri-bars. Reaches 750,000 outlets. GSK Consumer has a strong brand equity even in...
|
|
08 Nov 2012
|
GlaxoSmithKline
|
Chola Wealth Direct
|
10753.65
|
3198.00
|
3045.00
(253.16%)
|
|
Neutral
|
|
|
Background: GSK Consumer is the largest player in the Rs18b Indian health drink market, with a 70% market share. The category has entered a new orbit, with growth rates sustaining above 10%. Value-added variants of Horlicks account for ~18% of brand sales. With super premium MFDs priced at INR 1000 / Kg accounting for 10% of value and growing at 35%, GSK Consumer intends to enter the segment. Also, management aims to increase non-MFD segment's share from the current 5% to 15% over the next 3 years by focusing on Sensodyne toothpaste, noodles, oats, biscuits and nutri-bars. Reaches 750,000 outlets. GSK Consumer has a strong brand equity even in...
|